Renal Cell Carcinoma News

• ESMO 2020 A Glimmer of Hope for Immunotherapy in SCLC? While combination immunotherapy did not show a survival benefit after chemoradiotherapy in small cell lung cancer, longer follow-up and biomarker analysis may reveal some gains, suggests trial data.
  Medscape News UK, September 23, 2020
• ESMO 2020 Nivo-Cabo Combo Joins Advanced RCC Treatment Ranks The PD-1 inhibitor/TKI combination is the latest to show superior survival in comparison with sunitinib as first-line therapy for patients with metastatic renal cell carcinoma (RCC).
  Medscape Medical News, September 21, 2020
• ESMO 2020 The March of Immunotherapy Continues at ESMO 2020 At the ESMO 2020 Congress, there will be no shortage of advances in cancer care on display, say experts.
  Medscape Medical News, September 14, 2020
• Diabetes Linked to Increased Kidney Cancer Risk, But Only in Slim Postmenopausal women with BMIs under 30 are paradoxically more likely to develop kidney cancer than the women of the same age with higher BMIs and larger waists.
  Medscape Medical News, August 13, 2020
• Study Supports Changing Classification of Renal Cell Carcinoma The definition of stage 4 renal cell carcinoma should be expanded to include lymph node-positive stage 3 disease, according to a new study.
  Medscape Medical News, July 07, 2020
• AUA 2020 'Every Patient Would Applaud' Bladder Cancer Surveillance Study High-risk bladder cancer post-surgery follow-up is intensive and based on expert opinion. A new study questions that intensity and opinion.
  Medscape Medical News, May 21, 2020
• Alert FDA Approves Immunotherapy Combo for Liver Cancer Nivolumab and ipilimumab together produce a response rate double that of nivolumab alone in advanced hepatocellular carcinoma.
  FDA Approvals, March 11, 2020
• GUCS 2020 'Incredible' Results With Kidney Cancer Agent With Nobel Ties Once thought to be "undruggable," a target in renal cell carcinoma now has a drug aimed at it, and initial results from a small clinical trial are promising.
  Medscape Medical News, February 17, 2020
• More Than 50 Polyps in Some Young Cancer Survivors Pediatric and young adult cancer patients are at risk of developing numerous polyps (for some, more than 50 polyps) as a result of prior cancer treatment.
  Medscape Medical News, February 13, 2020
• 'Refinement of Surgical Treatment' Is ASCO Advance of the Year New systemic therapies have changed the role of surgery in several cancer tumor types, even eliminating the need for it in some cases.
  Medscape Medical News, February 12, 2020
• Adding Ilixadencel Improved Outcomes in Metastatic RCC Combining intratumoral injections of ilixadencel with sunitinib improved responses in patients with newly diagnosed synchronous metastatic renal cell carcinoma in the phase 2 MERECA trial.
  Medscape Medical News, February 11, 2020
• 'Overdiagnosis' in About 20% of Common Cancers A study from Australia that analyzed 30 years of national healthcare data suggests five common cancers are overdiagnosed in 18% of women and 24% of men.
  Medscape Medical News, January 30, 2020
• Fat Near Kidney Tumors May Explain 'Obesity Paradox' The fat surrounding a tumor — and not the tumor itself — appears to drive better cancer responses among obese patients compared with patients of normal weight.
  Medscape Medical News, January 23, 2020
• SCOS 2019 Cancer Patients Using Cannabis 'Doing Better…Feeling Better' Cannabis is increasingly being used by cancer patients, and at least some data show that it may help a variety of symptoms, including pain.
  Medscape Medical News, November 06, 2019
• ESMO 2019 One in Two Patients With Metastatic Melanoma Alive After 5 Years With the combination of ipilimumab and nivolumab, 50% of patients are still alive after 5 years, a survival rate remarkably higher than that seen with either agent alone.
  Medscape Medical News, September 28, 2019
• Family Members at Higher Risk for Blood Cancers First-degree relatives of a patient with blood cancer are at an increased risk of also being diagnosed, suggesting a shared etiology across hematologic malignancies.
  Medscape Medical News, September 09, 2019
• Obesity Effect on Cancer Risk Twice That Currently Thought A new analysis of genetic data suggests that the effect of obesity on cancer risk is much higher than currently estimated from observational studies.
  Medscape Medical News, August 16, 2019
• 'Functional Cure' in Advanced Cancer Suggested by Long-term Data Long-term survival data from one of the first trials conducted with nivolumab show that some patients are living for years, suggesting a 'functional cure at least' say the authors.
  Medscape Medical News, August 06, 2019
• FDA Okays Another Immunotherapy Plus TKI for Advanced RCC The FDA has approved avelumab in combination with the tyrosine kinase inhibitor (TKI) axitinib for the first-line treatment of advanced renal cell carcinoma (RCC).
  FDA Approvals, May 15, 2019
• Diabetes Tied to Cancer Risk in China, With Gender Differences "We suggest that establishing strategies for regular cancer-specific screening and prevention care among patients with [type 2 diabetes] are necessary," the authors conclude.
  Medscape Medical News, May 13, 2019